Skip to main content
. 2020 Nov 17;12(2):8365. doi: 10.4081/hr.2020.8365

Table 1.

Demographic and clinical data of studied thalassemia patients.

Variable Value
Age (years) 23±4
Gender
    M 23 (57.5%)
    F 17 (42.5%)
Type of thalassemia
    Thalassemia minor 5 (12.5%)
    Thalassemia intermedia 22 (55.0%)
    Thalassemia major 13 (32.5%)
Iron chelation therapy 15 (37.5%)
Splenectomy 11 (27.5%)
SGPT (IU/l) 52 (31–76)
SGOT (IU/l) 51 (31–73)
Urea (mg/dl) 25.5±4.2
Creatinine (mg/ml) 0.7±0.2
Hemoglobin (g/dl) 6.7±1.6
WBCs (x1000/mm3) 9.1 (6.6–13.7)
Platelets (x1000/mm3) 449 (303–720)
vWFa (IU/dl) 3.98 (1.65–6.00)

Data are mean ± SD, number (%) or median (interquartile range).